SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand

Background: In December 2021, Omicron replaced Delta as the dominant coronavirus disease 2019 (COVID-19) variant in Thailand. Both variants embody diverse epidemiological trends and immunogenicity. We investigated whether Delta and Omicron patients’ biological and clinical characteristics and immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongkolsucharitkul, Pichanun, Surawit, Apinya, Pumeiam, Sureeporn, Sookrung, Nitat, Tungtrongchitr, Anchalee, Phisalprapa, Pochamana, Sayabovorn, Naruemit, Srivanichakorn, Weerachai, Washirasaksiri, Chaiwat, Auesomwang, Chonticha, Sitasuwan, Tullaya, Chaisathaphol, Thanet, Tinmanee, Rungsima, Chayakulkeeree, Methee, Phoompoung, Pakpoom, Tangjittipokin, Watip, Senawong, Sansnee, Sanpawitayakul, Gornmigar, Muangman, Saipin, Mayurasakorn, Korapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318962/
https://www.ncbi.nlm.nih.gov/pubmed/35891295
http://dx.doi.org/10.3390/vaccines10071131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318962/
https://www.ncbi.nlm.nih.gov/pubmed/35891295
http://dx.doi.org/10.3390/vaccines10071131

Ejemplares similares